Please assess the completion status of the following clinical trial:

Trial Title: Propolis Effects in Patients With Chronic Kidney Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* older than 18 years;~* less than 90 years;~* glomerular filtration rate between 25 and 70 ml / min;~* proteinuria in the urine 24 hours more than 300 mg or protein / creatinina in isolated urine greater than 0.3g / g or microalbuminuria (albumin / creatinine ratio) between 30-300 mg / g.~Exclusion Criteria:~* Pregnants;~* Neoplasia carrier;~* Renal transplant patients;~* Patients who refuse to participate in the study.~* Glomerulopathy on Immunosuppression

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: t

Study Arms:
- Propolis (Type: ACTIVE_COMPARATOR): Patients will continue to receive standard treatment for their comorbidities, determined by the attending physician. Patients will receive 500 mg / day of the propolis extract in the form of tablets split in two daily doses.
- Placebo (Type: PLACEBO_COMPARATOR): Patients will continue to receive standard treatment for their comorbidities, determined by the attending physician. Patients will receive 500 mg / day of the propolis-placebo in the form of tablets split in two daily doses.

Based on this trial design, predict the completion outcome and termination type (if applicable).